| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fennec Pharmaceuticals Inc. (FENC) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. FENC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.74M | $18.58M | - | |
| CFO | 826.6K | $5.60M | - | |
| Dir | 225.0K | $1.52M | - | |
| Dir | 215.5K | $1.46M | - | |
| Dir | 174.3K | $1.18M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2025 | Rallis Chris A62 | Director | Sale+OE | 1,186 | $6.82 | $8,088.52 | -2.2% | -1.9% | +26.0% | |
| Feb 5, 2025 | Raykov Rosty55 | Director | Sell | 10,000 | $6.66 | $66,600.00 | -11.6% | -11.5% | +12.8% | |
| Jan 6, 2025 | Raykov Rosty55 | Director | Sell | 10,000 | $6.08 | $60,800.00 | -5.4% | -14.3% | +21.4% | |
| Dec 5, 2024 | Raykov Rosty55 | Director | Sell | 796 | $6.04 | $4,807.84 | -1.2% | +18.0% | +32.0% | |
| Dec 3, 2024 | Raykov Rosty55 | Director | Sell | 1,635 | $6.13 | $10,022.55 | -2.4% | +8.7% | +21.5% | |
| Dec 2, 2024 | Rallis Chris A62 | Director | Sale+OE | 6,409 | $6.14 | $39,351.26 | -10.9% | +8.5% | +22.0% | |
| Nov 4, 2024 | Raykov Rosty55 | Director | Sell | 2,431 | $4.31 | $10,477.61 | -3.5% | +39.8% | +72.0% | |
| Oct 8, 2024 | Rallis Chris A62 | Director | Sale+OE | 1,406 | $4.53 | $6,369.18 | -2.8% | +34.8% | +104.4% | |
| Oct 1, 2024 | Raykov Rosty55 | Director | Sell | 2,431 | $4.94 | $12,009.14 | -3.5% | +27.8% | +99.0% | |
| Sep 4, 2024 | Raykov Rosty55 | Director | Sell | 2,431 | $5.52 | $13,419.12 | -3.5% | +12.1% | +65.1% |